Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC.PACB · Entity 5650 | See Remarks | March 02, 2022 | March 05, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Report date March 02, 2022 · Filed March 05, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 190,280 |
Reported balance
After 2022-03-02 transaction · row 1
1 source rowRow 1 · 2022-03-02 · Grant · Acquired 50,000 · Balance 190,280 F1: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on March 2 of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.70 · Expires 2032-03-02 | Direct | 298,700 |
Reported balance
After 2022-03-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-03-02 · Grant · Acquired 298,700 · Balance 298,700 F2: The shares subject to the option will vest in equal monthly installments over the next four years, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on March 2 of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates.
F2: The shares subject to the option will vest in equal monthly installments over the next four years, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2022 Filed Mar 5, 2022 00:26 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantStock Option (right to buy) · Derivative | 298,700 | $0.00 Strike: $11.70 | $0.00 |
DisclosureSEC source: 0001299130-22-000037 · certent-form4.xml · derivative · entry 2 Fromen Peter · CIK 0001838928 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,700 Underlying: Common Stock · 298,700 shares Expires 2032-03-02 F2 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the next four years, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates. Read SEC document |
| March 02, 2022 Filed Mar 5, 2022 00:26 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001299130-22-000037 · certent-form4.xml · nonDerivative · entry 1 Fromen Peter · CIK 0001838928 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,280 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on March 2 of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates. Read SEC document |
| January 11, 2022 Filed Jan 13, 2022 23:13 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | SaleCommon Stock | 19,720 | $14.30 | $281,996.00 |
DisclosureSEC source: 0001299130-22-000010 · certent-form4.xml · nonDerivative · entry 1 Fromen Peter · CIK 0001838928 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,280 F1 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units. F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $14.30 to $14.34 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 23:17 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantStock Option (right to buy) · Derivative | 320,000 | $0.00 Strike: $36.70 | $0.00 |
DisclosureSEC source: 0001299130-21-000026 · certent-form4.xml · derivative · entry 2 Fromen Peter · CIK 0001838928 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,000 Underlying: Common Stock · 320,000 shares Expires 2031-01-08 F2 · derivative.exercise_date: 1/4 of the shares subject to the option will vest on the one year anniversary of the date of grant, and the balance of shares will vest monthly thereafter over the next three years, provided that the Reporting Person continues to serve through each vesting date. Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 23:17 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantCommon Stock | 160,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001299130-21-000026 · certent-form4.xml · nonDerivative · entry 1 Fromen Peter · CIK 0001838928 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on January 8 of each of 2022, 2023, 2024, and 2025, provided that the Reporting Person continues to serve through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.